Article
Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
International journal of cancer - 1 Aug 2009
Tritschler Isabel, Gramatzki Dorothee, Capper David, Mittelbronn Michel, Meyermann Richard, Saharinen Juha, Wick Wolfgang, Keski-Oja Jorma, Weller Michael
Abstract excerpt
High biological activity of the transforming growth factor (TGF)-beta-Smad pathway characterizes the malignant phenotype of malignant gliomas and confers poor prognosis to glioma patients. Accordingly, TGF-beta has become a novel target for the experimental treatment of these tumors. TGF-beta is processed by furin-like proteases (FLP) and secreted from cells in a latent complex with its processed propeptide, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
